CDC notes link between jump in acute HCV cases and admissions to substance use disorder treatment facilities for opioid injections.
Patients with a high risk of recurrent breast cancer may not receive chemotherapy.
Sandoz proposed adalimumab biosimilar demonstrates similarity to reference product in safety, efficacy, and quality measures.
Novel HIV treatment protected immune cells against HIV for nearly a month.
More than one-third of HIV-positive patients are not vaccinated against hepatitis B virus.
FDA grants priority approval to arsenic trioxide (Trisenox) plus tretinoin for leukemia treatment.
Afatinib (Gilotrif) found to improve overall survival among patients with EGFR-mutated non-small cell lung cancer.

Most Popular

Company Profile >
Contributors >
Industry Guide >
Market News >
Peer Exchange >
Conferences >
Subscribe >
Specialty Times Resources
About Us
Contact Us
Terms & Conditions
MJH Associates >
Pharmacy Times
American Journal of Managed Care
MD Magazine
Targeted Oncology
Physicians' Education Resource
Pharmacy & Healthcare Communications, LLC
2 Clarke Drive
Suite 100
Cranbury, NJ 08512
P: 609-716-7777
F: 609-716-4747

Copyright Specialty Pharmacy Times 2006-2017
Pharmacy & Healthcare Communications, LLC. All Rights Reserved.